Regular Article
Elevated Systemic Elimination of Cimetidine in Rats with Acute Biliary Obstruction: The Role of Renal Organic Cation Transporter OCT2

https://doi.org/10.2133/dmpk.DMPK-10-RG-004Get rights and content

Summary:

Renal tubular secretion of cationic drugs is dominated by two classes of organic cation transporters, OCT2/SLC22A2 and MATE1/SLC47A1, localized to the basolateral and brush-border membranes of the renal tubular epithelial cells, respectively. However, little is known about the expression and function of these transporters in acute cholestasis. Systemic clearance of cimetidine was significantly higher in rats with bile duct ligation (BDL) for 24 hours than in sham-operated rats, with no significant changes in the volume of distribution between the groups. In addition, net tubular secretory clearance of cimetidine was significantly higher in the BDL rats compared with the sham rats, with no significant changes in the glomerular filtration rate. Moreover, the renal tissue-to-plasma concentration ratio of cimetidine was elevated in BDL rats, although the renal tissue-to-urine clearance ratio of cimetidine was not different between the two groups. The expression level of basolateral organic cation transporter rOCT2 protein in the kidney cortex was markedly higher in BDL rats than that in the sham rats, but that of H+/organic cation antiporter rMATE1 protein in the brush-border membranes was not significantly different between the two groups. These results demonstrate that the renal tubular secretion of cimetidine was increased by acute cholestasis, and this increase was attribut-able to elevated expression levels of rOCT2 but not of rMATE1 in the rat.

References (30)

  • Y. Urakami et al.

    Hormonal regulation of organic cation transporter OCT2 expression in rat kidney

    FEBS Lett.

    (2000)
  • H. Motohashi et al.

    Gene expression levels and immunolocalization of organic ion transporters in the human kidney

    J. Am. Soc. Nephrol.

    (2002)
  • Y. Urakami et al.

    Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules

    Pharm. Res.

    (2001)
  • M. Otsuka et al.

    A human transporter protein that mediates the final excretion step for toxic organic cations

    Proc. Natl. Acad. Sci. U.S.A.

    (2005)
  • A. Grahnen et al.

    Bioavailability and pharmacokinetics of cimetidine

    Eur. J. Clin. Pharmacol.

    (1979)
  • Cited by (27)

    • Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin

      2023, Acta Pharmaceutica Sinica B
      Citation Excerpt :

      Several studies have demonstrated that liver injury alters expressions of OCTs in liver and kidney, which are dependent on type of liver failure and OCT species. For example, liver injury induced by ischemia‒reperfusion downregulates expressions of renal Oct2 and Mate1, leading to decreases in systemic and tubular secretory clearance of cimetidine20. Significant downregulation of hepatic Oct1 and renal Oct2 are also observed in ethynylestradiol-induced cholestasis rats19.

    • Increased Expression of Renal Drug Transporters in a Mouse Model of Familial Alzheimer's Disease

      2019, Journal of Pharmaceutical Sciences
      Citation Excerpt :

      The increased expression of Oct2 suggests that the renal clearance of pindolol, and other substrates of this cationic transporter, would be increased in AD. A previous study has reported that the renal expression and function of Oct2 were significantly increased in rats with acute biliary obstruction,28 suggesting that the increase in renal Oct2 we observed in APP/PS1 mice may also result from increased plasma concentrations of bile acids, as described for Mrp2. Proteomic analysis also identified a significant increase in the expression of Oat3, a solute-linked carrier protein expressed at the basolateral membrane of renal proximal tubular epithelial cells.

    • JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats

      2013, Toxicology and Applied Pharmacology
      Citation Excerpt :

      Mannitol is a diuretic agent, commonly used in the perioperative setting due to its renoprotective properties. It is freely filtered in the glomerulus and due to its limited reabsorption it creates sufficient osmotic force in the kidney tubules to inhibit the reabsorption of fluids and solutes along the nephron (Bengt et al., 2009; Kurata et al., 2010; Robert et al., 2004). PEPT2 is localized at the brush-border membranes of proximal tubules, and mediates the reabsorption of dipeptides and ACEIs, such as JBP485 and lisinopril (Guo et al., 2012a, 2012b).

    View all citing articles on Scopus

    This work was supported by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C) 20590143].

    View full text